Vaccin- och bioteknikbolaget Abera Biosciences board member Mats Wahlström transfers 126,739 warrants to the company’s management, staff and other board members, according to a press release. The total value amounts to approximately SEK 1 million. CEO Maria Alriksson and research director Mats Lundberg each buy 40,000 warrants for SEK 328,000.- For me, who already has a significant holding, it is important that the board and management have the same interests as the other shareholders through personal ownership in the company. This gives management the opportunity to, together with all shareholders, take part in the value growth created through the company’s success. It is gratifying to see the confidence and commitment that management shows by investing in the company through the exercise of the warrants, says Mats Wahlström.